Stay updated on Pyrotinib+Trastuzumab+Docetaxel in HER2+ Metastatic Breast Ca Clinical Trial

Sign up to get notified when there's something new on the Pyrotinib+Trastuzumab+Docetaxel in HER2+ Metastatic Breast Ca Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pyrotinib+Trastuzumab+Docetaxel in HER2+ Metastatic Breast Ca Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    A new revision entry v3.6.3 was added to the study record history, and the older v3.6.0 entry was removed.
    Difference
    0.1%
    Check dated 2026-06-30T01:57:45.000Z thumbnail image
  4. Check
    31 days ago
    Change Detected
    Summary
    Added 'Last verified' and 'Last known status was' fields to the record history and updated the revision label to 'Revision: v3.6.0' to reflect the latest data verification and versioning.
    Difference
    2%
    Check dated 2026-06-15T19:13:32.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The record history shows Revision: v3.5.5 replacing Revision: v3.5.4, indicating a new build/version of the ClinicalTrials.gov history interface.
    Difference
    0.1%
    Check dated 2026-06-08T16:27:21.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Added a new revision entry (v3.5.4) to the Study Record Versions, replacing the previous v3.5.3. This updates the revision history for the study.
    Difference
    0.1%
    Check dated 2026-05-18T04:00:25.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov interface revision indicator has been updated from v3.5.0 to v3.5.3, reflecting a change to the site/versioning rather than the underlying trial history or study information.
    Difference
    0.1%
    Check dated 2026-04-26T15:23:12.000Z thumbnail image
  8. Check
    117 days ago
    Change Detected
    Summary
    Record history adds v3.5.0 and removes v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-21T18:49:08.000Z thumbnail image

Stay in the know with updates to Pyrotinib+Trastuzumab+Docetaxel in HER2+ Metastatic Breast Ca Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pyrotinib+Trastuzumab+Docetaxel in HER2+ Metastatic Breast Ca Clinical Trial page.